Pharmaceutical Technology Europe-02-01-2012

News
Pharmaceutical Technology Europe

February 01, 2012

How can pharma make use of social media opportunities without running afoul of regulators?

Pharmaceutical Technology Europe
Ask the Expert

February 01, 2012

We interview Subhro Mallik from IT firm Infosys about how pharma is responding to the cloud computing phenomenon and what more can be done to realise business benefits.

Pharmaceutical Technology Europe

February 01, 2012

"The patent expiry of several major blockbuster drugs worth $150 billion between 2010 and 2017 will fuel the growth of the global generic pharmaceuticals market," so says a press release announcing new analysis from Frost & Sullivan.

Pharmaceutical Technology Europe
Industry Insider

February 01, 2012

The scandal surrounding Servier's diabetes drug, Mediator, continues to unravel in France and could have implications for the whole pharmaceutical industry as the country scrutinises its regulatory systems.

Pharmaceutical Technology Europe
Disposables Advisor

February 01, 2012

This column will address some of the questions on how single use systems are sterilized by gamma irradiation and what documentation may be requested by regulators.

Peer-Reviewed Research
Pharmaceutical Technology Europe

February 01, 2012

In Part I of a three-part article, the authors discuss what constitutes an impurity and the potential sources of impurities in APIs and finished drug products.

Pharmaceutical Technology Europe

Does nanotechnology offer a cure-all or a kill all? We speak with Ruth Duncan about the real potential of nanomedicines.

Pharmaceutical Technology Europe
Special Feature

February 01, 2012

We bring industry experts together to discuss the importance of self-administration and what injection technologies are best suited to this cause.